Acute Kidney Injury News

Patients who received follow-up care at a specialized clinic following AKI had a lower risk for rehospitalization than patients who received usual care, investigators from the University of Kentucky Medical Center found.

Rheumatologists opt for therapy regimens that include rituximab more often than nephrologists in treating refractory lupus nephritis or renal flare in children, according to data published in Pediatric Rheumatology.

Individuals who survived for at least 30 days after contracting COVID-19 — considered the acute phase of the illness — were at greater risk for adverse kidney outcomes, even if the infection was deemed mild, study results showed.

For patients with atrial fibrillation, the risk for AKI was lower in those who were prescribed a direct oral anticoagulant than in those prescribed warfarin.

A speaker at the virtual Innovations in Dialysis: Expediting Advances Symposium discussed the high incidence of AKI among patients hospitalized with COVID-19 and speculated on why these rates differ across studies.

Deceased donor AKI, both ongoing and recovery, was associated with higher rates of graft failure following kidney transplantation, a study that determined AKI using a back-estimation of baseline serum creatinine showed.

AKI was more common in hospitalizations for COVID-19 than influenza, with study results indicating that AKI with the former led to more severe outcomes, including the need for mechanical ventilation and increased mortality.

Obesity is not associated with an increased risk for death for adults admitted to the ICU with COVID-19, but BMI is linked to acute respiratory distress syndrome in these patients, according to a study published in Obesity.

For patients hospitalized with COVID-19, a boosted decision tree model more accurately predicted AKI requiring dialysis and mortality compared with either standard models or other machine learning models.

Applying a risk progression classification system to patients with a sepsis-associated kidney injury can aid nephrologists in predicting long-term kidney outcomes, results show.